Evidence map›Paper›PMID 27529638›Full record

ArticleBioconjugate chemistry2016

Site-Directed Glycosylation of Peptide/Protein with Homogeneous O-Linked Eukaryotic N-Glycans.

Zhigang Wu, Kuan Jiang, Hailiang Zhu, Cheng Ma, Zaikuan Yu, Lei Li, Wanyi Guan, Yunpeng Liu, He Zhu, Yanyi Chen and 5 more

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhigang WuDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Kuan JiangState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University , Tianjin 300353, China.
Hailiang ZhuDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Cheng MaDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Zaikuan YuDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Lei LiDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Wanyi GuanDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Yunpeng LiuDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
He ZhuDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Yanyi ChenDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Shanshan LiDepartment of Chemistry, Georgia State University , Atlanta, Georgia 30303, United States.
Jing LiState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University , Tianjin 300353, China.
Jiansong ChengState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University , Tianjin 300353, China.
Lianwen ZhangState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University , Tianjin 300353, China.
Peng George WangState Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University , Tianjin 300353, China.

Funding

Biosynthesis of PolysaccharidesR01GM085267 · NIGMS · OHIO STATE UNIVERSITY · PI WANG, PENG GEORGE · 2009 to 2017
$2.4M
Facile Synthesis of O-Glycans and O-GlycopeptidesU01GM116263 · NIGMS · GEORGIA STATE UNIVERSITY · PI LI, LEI · 2015 to 2018
$2.2M
NIGMS NIH HHS R01 GM085267NIGMS NIH HHS U01 GM116263
6 · The paper itself

Abstract

Here we report a facile and efficient method for site-directed glycosylation of peptide/protein. The method contains two sequential steps: generation of a GlcNAc-O-peptide/protein, and subsequent ligation of a eukaryotic N-glycan to the GlcNAc moiety. A pharmaceutical peptide, glucagon-like peptide-1 (GLP-1), and a model protein, bovine α-Crystallin, were successfully glycosylated using such an approach. It was shown that the GLP-1 with O-linked N-glycan maintained an unchanged secondary structure after glycosylation, suggesting the potential application of this approach for peptide/protein drug production. In summary, the coupled approach provides a general strategy to produce homogeneous glycopeptide/glycoprotein bearing eukaryotic N-glycans.

Indexed as

Acetylglucosaminealpha-CrystallinsAmino Acid SequenceAnimalsBinding SitesCattleEukaryotic CellsGlucagon-Like Peptide 1GlycosylationPolysaccharidesAcetylglucosaminealpha-CrystallinsGlucagon-Like Peptide 1Polysaccharides

Identifiers

PMID27529638
PMCPMC5951161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.